AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation Congress Pharmaceutical Investing
Ginkgo Bioworks Provides Compensation Information Related to Recent Acquisitions Life Science Investing
AbbVie Announces Provincial Reimbursement for RINVOQ® for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis in Alberta, New Brunswick, Ontario, Quebec and Saskatchewan Pharmaceutical Investing
Aurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® for the Treatment of Lupus Nephritis Pharmaceutical Investing
IPA's Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies Pharmaceutical Investing
European Commission Grants Expanded Marketing Authorization for Gilead's Biktarvy® for the Treatment of HIV in Pediatric Populations Pharmaceutical Investing
